ĀÜĄņĀŅĀ×

Robin L. Washington is currently a member of the Board of Directors of Alphabet, Inc., Honeywell International, Inc., Salesforce.com and Eikon Therapeutics. She currently serves as chair of the leadership development inclusion and compensation committee for Alphabet and chair of the audit committee for Salesforce.com. She is also a member of the Presidents Council & Ross Business School Advisory Board, University of Michigan; the UCSF Benioff Childrenā€™s Hospital Oakland, and a trustee of the Financial Accounting Foundation.

Ms. Washington served as Executive Vice President and Chief Financial Officer of Gilead Sciences, Inc., a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines to improve the care of patients with life-threatening diseases, from May 2008 ā€“ November 2019 where she oversaw Global Finance, Facilities and Operations, Investor Relations and the Information Technology organizations. She served as a Sr. Advisor to the Gilead until her retirement on March 1, 2020. Prior to Gilead, Ms. Washington was the Chief Financial Officer of Hyperion Solutions Inc., an enterprise software company providing business performance management solutions for global enterprises that were acquired by Oracle Corporation. Previously, she also served as Senior Vice President and Corporate Controller of PeopleSoft, a provider of enterprise application software that was also acquired by Oracle Corporation. Prior to PeopleSoft, Ms. Washington was Director of Finance for Tandem Computers, an Accounting Analyst for the Federal Reserve Bank of Chicago, and a Senior Auditor for Deloitte & Touche.